Pharma giant Eli Lilly has launched a new anti-obesity and diabetes drug in India called Mounjaro. But should you take ...

Obesity affects approximately 100 million Indian adults and is linked to over 200 health complications, including heart ...

US giant, Eli Lilly launched Mounjaro (tirzepatide) which is a prescription medicine for adults with type 2 diabetes used ...

American pharmaceutical company Eli Lilly has launched its drug, Mounjaro, in India. Mounjaro is administered as a ...

ELi Lilly Weight Loss Drug: Popular anti-diabetes and obesity drug Mounjaro has been launched in India in a single-dose vial. While it has already been in strong demand in the US and Europe, the India ...

Copycat versions of Eli Lilly's diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They're still available on some websites.

Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.

Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India following approval from the country's drug ...

Key health developments include the White House considering Michael Burgess for CDC leadership, rising measles cases in Texas ...

Vantage with Palki Sharma | N18G Eli Lilly’s blockbuster diabetes drug, Mounjaro, has officially launched in India — sparking a new battle for the country’s waistline. This comes as the country gears ...

Mughal ruler Aurangzeb’s grave in Maharashtra’s Khuldabad has become a target of fringe right-wing groups, who are demanding its demolition. The 17th-century emperor is once again back in the news and ...

TV18’s daily newsletter featuring the top 10 stories on markets, corporate updates, economic insights, and financial ...